Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xianyaoyin
- Development stage
- Unknown
- Lead developer
- Xiyuan Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xianyaoyin is a Traditional Chinese Medicine (TCM) hospital preparation developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of hypertriglyceridemia and simple obesity. The formulation is a combination of several herbal components, typically including *Folium Nelumbinis* (Lotus leaf), *Semen Cassiae* (Cassia seed), *Rhizoma Alismatis* (Water Plantain), and *Fructus Crataegi* (Hawthorn). Xianyaoyin is designed to regulate lipid metabolism and promote weight loss by addressing 'phlegm-dampness' and 'spleen deficiency' according to TCM principles. Clinical research conducted at Xiyuan Hospital has demonstrated its efficacy in significantly reducing serum triglyceride levels, total cholesterol, and body mass index (BMI) in patients with metabolic disorders. As an 'in-hospital preparation' (院内制剂), it is approved for clinical use within the developing institution and its affiliated medical network in Beijing, China.
- Brand names
- Xianyaoyin
- Other names
- Xianyao Yin纤腰饮
02
Targets
PNLIP (Pancreatic triacylglycerol lipase)PPARA (Peroxisome proliferator-activated receptor alpha)
Beyond the preview
Go deeper on Xianyaoyin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xianyaoyin.